MR-guided radiation plus nanoparticles for central lung or pancreatic tumors
Part of Cancer, Lungs & breathing clinical trials.
This early-phase study tests a new way to deliver focused radiation using MRI guidance and tiny particles, aiming to treat certain central lung tumors or locally advanced pancreatic cancer. It’s designed to see how safe it is and how well it can control these tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed non-small cell lung cancer (NSCLC) in a central area, or pancreatic ductal adenocarcinoma in the pancreas
- Your cancer can be measured on scans (a visible spot at least 20 mm on standard imaging, or 10 mm on specific CT/MRI methods)
- If you have lung cancer: it must be unresectable or you can’t have surgery, and there must be no lymph node spread (N0); tumor size must be 5 cm or less
- If you have pancreatic cancer: it must be locally advanced/unresectable (near major blood vessels) and you must have finished at least 3 months of standard chemotherapy with no more than a 10-week break before this study
- No distant spread (no metastases), and you must be at least 18 with good enough blood counts and organ function
- You must be able to follow breathing instructions for the MRI-guided treatment, and you must be willing to use birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of giving radiation therapy for advanced lung cancer that cannot be surgically removed. It uses MRI scans to guide and adjust the radiation dose, which may help target the tumor more precisely and reduce side effects.
This trial tests a new treatment that uses tiny alpha radiation sources placed directly into the tumor to destroy cancer cells. It is for people with pancreatic cancer that has not spread but cannot be removed surgically, and who have already tried at least one type of chemotherapy or cannot take more chemo.
This study tests a type of high-precision radiation guided by MRI pictures to treat certain cancers. It may help doctors deliver radiation more accurately while avoiding nearby healthy tissue, but you must be able to safely complete an MRI scan and meet tumor-size and health requirements.
This trial tests a new type of MRI-guided radiation therapy for people with locally advanced pancreatic cancer that can't be removed by surgery. If you have already had 2 months of chemotherapy, or chose not to, this treatment might help control the tumor.
This study tests a highly focused radiation plan that uses MRI scans to adjust treatment during therapy. It’s for people with locally advanced pancreatic cancer who have already completed a set course of chemotherapy and whose cancer hasn’t grown.
This trial tests a higher dose of radiation guided by MRI for people with pancreatic cancer that cannot be removed by surgery or is borderline removable. It aims to improve treatment effectiveness after initial chemotherapy.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.